Signal2026-07-09
ClinicalTrials.gov

[PHASE2] IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

Part of

Prostate Cancer Biomarker And Treatment Research

Open primary sourceRead on Substack